{"id":"https://openalex.org/W7170067503","doi":"https://doi.org/10.1056/nejmoa2601486","title":"Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer","display_name":"Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer","publication_year":2026,"publication_date":"2026-07-22","ids":{"openalex":"https://openalex.org/W7170067503","doi":"https://doi.org/10.1056/nejmoa2601486","pmid":"https://pubmed.ncbi.nlm.nih.gov/42485627"},"language":"en","primary_location":{"id":"doi:10.1056/nejmoa2601486","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejmoa2601486","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035236573","display_name":"M. Galsky","orcid":null},"institutions":[{"id":"https://openalex.org/I4210095266","display_name":"Mount Sinai Medical Center","ror":"https://ror.org/00wgjpw02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210095266"]},{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew D. Galsky","raw_affiliation_strings":["Mount Sinai Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mount Sinai Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York","institution_ids":["https://openalex.org/I4210095266","https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132803556","display_name":"Bego\u00f1a P. Valderrama","orcid":null},"institutions":[{"id":"https://openalex.org/I4210153139","display_name":"Hospital Universitario Virgen del Roc\u00edo","ror":"https://ror.org/04vfhnm78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210153139"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Bego\u00f1a P. Valderrama","raw_affiliation_strings":["Hospital Universitario Virgen del Roc\u00edo, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen del Roc\u00edo, Seville, Spain","institution_ids":["https://openalex.org/I4210153139"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034433849","display_name":"Marco Maruzzo","orcid":"https://orcid.org/0000-0002-6256-9249"},"institutions":[{"id":"https://openalex.org/I4210109345","display_name":"Istituto Oncologico Veneto","ror":"https://ror.org/01xcjmy57","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210109345","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Maruzzo","raw_affiliation_strings":["Istituto Oncologico Veneto (IOV)\u2013IRCCS, Padua, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Oncologico Veneto (IOV)\u2013IRCCS, Padua, Italy","institution_ids":["https://openalex.org/I4210109345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5143430528","display_name":"Albert Font","orcid":null},"institutions":[{"id":"https://openalex.org/I4210137002","display_name":"Institut d'Investigaci\u00f3 en Ci\u00e8ncies de la Salut Germans Trias i Pujol","ror":"https://ror.org/03bzdww12","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210137002","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Albert Font","raw_affiliation_strings":["Catalan Institute of Oncology Badalona, Badalona Applied Research Group in Oncology, Translational Program in Cancer Research, Institut Germans Trias i Pujol, Barcelona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Catalan Institute of Oncology Badalona, Badalona Applied Research Group in Oncology, Translational Program in Cancer Research, Institut Germans Trias i Pujol, Barcelona","institution_ids":["https://openalex.org/I4210137002"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5126318960","display_name":"Tudor Ciuleanu","orcid":null},"institutions":[{"id":"https://openalex.org/I4210100616","display_name":"Institute of Oncology Prof. Dr. Ion Chiricuta","ror":"https://ror.org/00nrbsf87","country_code":"RO","type":"facility","lineage":["https://openalex.org/I4210100616"]}],"countries":["RO"],"is_corresponding":false,"raw_author_name":"Tudor Ciuleanu","raw_affiliation_strings":["Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca, Romania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca, Romania","institution_ids":["https://openalex.org/I4210100616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136932670","display_name":"Jonathan Chatzkel","orcid":null},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Chatzkel","raw_affiliation_strings":["University of Florida, Gainesville"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5143451111","display_name":"Takuya Koie","orcid":null},"institutions":[{"id":"https://openalex.org/I42405503","display_name":"Gifu University","ror":"https://ror.org/024exxj48","country_code":"JP","type":"education","lineage":["https://openalex.org/I42405503"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takuya Koie","raw_affiliation_strings":["Department of Urology, Gifu University Graduate School of Medicine, Gifu, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Gifu University Graduate School of Medicine, Gifu, Japan","institution_ids":["https://openalex.org/I42405503"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5143408299","display_name":"Christopher J. Hoimes","orcid":null},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher J. Hoimes","raw_affiliation_strings":["Duke Cancer Institute, Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Cancer Institute, Duke University, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5143456562","display_name":"Javier Puente","orcid":null},"institutions":[{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier Puente","raw_affiliation_strings":["Hospital Cl\u00ednico Universitario San Carlos de Madrid, Madrid"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Cl\u00ednico Universitario San Carlos de Madrid, Madrid","institution_ids":["https://openalex.org/I2961216182"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136533048","display_name":"Yousef Zakharia","orcid":"https://orcid.org/0000-0001-9480-2626"},"institutions":[{"id":"https://openalex.org/I2802216851","display_name":"University of Iowa Hospitals and Clinics","ror":"https://ror.org/04g2swc55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I126307644","https://openalex.org/I2802216851"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yousef Zakharia","raw_affiliation_strings":["University of Iowa Hospital and Clinics, Iowa City"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Iowa Hospital and Clinics, Iowa City","institution_ids":["https://openalex.org/I2802216851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020715864","display_name":"Eli Rosenbaum","orcid":null},"institutions":[{"id":"https://openalex.org/I2800389475","display_name":"Rabin Medical Center","ror":"https://ror.org/01vjtf564","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2800389475","https://openalex.org/I64767286"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Eli Rosenbaum","raw_affiliation_strings":["Rabin Medical Center, Davidoff Cancer Center, Petah Tikva, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rabin Medical Center, Davidoff Cancer Center, Petah Tikva, Israel","institution_ids":["https://openalex.org/I2800389475"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5137094482","display_name":"Katharina Boehm","orcid":null},"institutions":[{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Katharina Boehm","raw_affiliation_strings":["University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany","institution_ids":["https://openalex.org/I4210162051"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5143418096","display_name":"Yohann Loriot","orcid":null},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Yohann Loriot","raw_affiliation_strings":["Universit\u00e9 Paris-Saclay, Gustave Roussy, INSERM Unit\u00e9 Mixte de Recherche 981 \u2014 Pr\u00e9dicteurs Mol\u00e9culaires et Nouvelles Cibles en Oncologie, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 Paris-Saclay, Gustave Roussy, INSERM Unit\u00e9 Mixte de Recherche 981 \u2014 Pr\u00e9dicteurs Mol\u00e9culaires et Nouvelles Cibles en Oncologie, Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I277688954","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5143434838","display_name":"Jens Bedke","orcid":null},"institutions":[{"id":"https://openalex.org/I4210161485","display_name":"Klinikum Stuttgart","ror":"https://ror.org/059jfth35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210161485"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jens Bedke","raw_affiliation_strings":["Department of Urology and Transplantation Surgery, Klinikum Stuttgart, Stuttgart, Germany","Eva Mayr-Stihl Cancer Center, Klinikum Stuttgart, Stuttgart, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology and Transplantation Surgery, Klinikum Stuttgart, Stuttgart, Germany","institution_ids":["https://openalex.org/I4210161485"]},{"raw_affiliation_string":"Eva Mayr-Stihl Cancer Center, Klinikum Stuttgart, Stuttgart, Germany","institution_ids":["https://openalex.org/I4210161485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089861374","display_name":"Thomas Powles","orcid":"https://orcid.org/0000-0001-7760-4724"},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I225661044","display_name":"Barts Health NHS Trust","ror":"https://ror.org/00b31g692","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Thomas B. Powles","raw_affiliation_strings":["Barts Health NHS Trust, Barts Cancer Institute, Queen Mary University of London, London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barts Health NHS Trust, Barts Cancer Institute, Queen Mary University of London, London","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I225661044"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083331837","display_name":"Andrea Necchi","orcid":"https://orcid.org/0000-0002-3007-2756"},"institutions":[{"id":"https://openalex.org/I154387261","display_name":"Vita-Salute San Raffaele University","ror":"https://ror.org/01gmqr298","country_code":"IT","type":"education","lineage":["https://openalex.org/I154387261"]},{"id":"https://openalex.org/I4210105552","display_name":"Mylan (South Africa)","ror":"https://ror.org/01gqqqf26","country_code":"ZA","type":"company","lineage":["https://openalex.org/I4210105552","https://openalex.org/I4210159288"]}],"countries":["IT","ZA"],"is_corresponding":false,"raw_author_name":"Andrea Necchi","raw_affiliation_strings":["Department of Medical Oncology, IRCCS San Raffaele Hospital, Comprehensive Cancer Center, Milan","Vita-Salute San Raffaele University, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, IRCCS San Raffaele Hospital, Comprehensive Cancer Center, Milan","institution_ids":["https://openalex.org/I154387261"]},{"raw_affiliation_string":"Vita-Salute San Raffaele University, Milan","institution_ids":["https://openalex.org/I154387261","https://openalex.org/I4210105552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040234777","display_name":"Pawe\u0142 Wiechno","orcid":null},"institutions":[{"id":"https://openalex.org/I4210144815","display_name":"Lasy Pa\u0144stwowe","ror":"https://ror.org/04et4d930","country_code":"PL","type":"government","lineage":["https://openalex.org/I4210144815"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Pawel Wiechno","raw_affiliation_strings":["Klinika Nowotwor\u00f3w Uk\u0142adu Moczowego, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Klinika Nowotwor\u00f3w Uk\u0142adu Moczowego, Warsaw, Poland","institution_ids":["https://openalex.org/I4210144815"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041104141","display_name":"Carlos \u00c1lvarez-Fern\u00e1ndez","orcid":"https://orcid.org/0000-0002-2500-074X"},"institutions":[{"id":"https://openalex.org/I4210133994","display_name":"Hospital Universitario Central de Asturias","ror":"https://ror.org/03v85ar63","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210133994","https://openalex.org/I4405258403"]},{"id":"https://openalex.org/I4210166274","display_name":"Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias","ror":"https://ror.org/05xzb7x97","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210166274"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carlos \u00c1lvarez-Fern\u00e1ndez","raw_affiliation_strings":["Hospital Universitario Central de Asturias, Oviedo, Spain","Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias, Oviedo, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Central de Asturias, Oviedo, Spain","institution_ids":["https://openalex.org/I4210133994"]},{"raw_affiliation_string":"Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias, Oviedo, Spain","institution_ids":["https://openalex.org/I4210166274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100434365","display_name":"Tae\u2010Hwan Kim","orcid":"https://orcid.org/0000-0002-3542-2276"},"institutions":[{"id":"https://openalex.org/I2801673063","display_name":"Kyungpook National University Hospital","ror":"https://ror.org/04qn0xg47","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2801673063","https://openalex.org/I31419693"]},{"id":"https://openalex.org/I31419693","display_name":"Kyungpook National University","ror":"https://ror.org/040c17130","country_code":"KR","type":"education","lineage":["https://openalex.org/I31419693"]},{"id":"https://openalex.org/I4405258372","display_name":"Kyungpook National University Chilgok Hospital","ror":"https://ror.org/00hyr5m88","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2801673063","https://openalex.org/I31419693","https://openalex.org/I4405258372"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Tae-Hwan Kim","raw_affiliation_strings":["Department of Urology, Kyungpook National University Chilgok Hospital, Daegu, South Korea","Department of Urology, Kyungpook National University School of Medicine, Daegu, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Kyungpook National University Chilgok Hospital, Daegu, South Korea","institution_ids":["https://openalex.org/I2801673063","https://openalex.org/I4405258372"]},{"raw_affiliation_string":"Department of Urology, Kyungpook National University School of Medicine, Daegu, South Korea","institution_ids":["https://openalex.org/I31419693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5140489228","display_name":"Niara Oliveira","orcid":null},"institutions":[{"id":"https://openalex.org/I1316052090","display_name":"Mater Health Services","ror":"https://ror.org/03mjtdk61","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1316052090"]},{"id":"https://openalex.org/I2801568770","display_name":"Mater Misericordiae Hospital","ror":"https://ror.org/01k4cfw02","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1316052090","https://openalex.org/I2801568770"]},{"id":"https://openalex.org/I4210092543","display_name":"Mater Research","ror":"https://ror.org/00nx6aa03","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210092543"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Niara Oliveira","raw_affiliation_strings":["Mater Hospital Brisbane, Mater Misericordiae, Brisbane, QLD, Australia","School of Clinical Medicine, Mater Clinical Unit, University of Queensland, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mater Hospital Brisbane, Mater Misericordiae, Brisbane, QLD, Australia","institution_ids":["https://openalex.org/I2801568770"]},{"raw_affiliation_string":"School of Clinical Medicine, Mater Clinical Unit, University of Queensland, Brisbane, Australia","institution_ids":["https://openalex.org/I1316052090","https://openalex.org/I4210092543"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088312939","display_name":"Thomas W. Flaig","orcid":"https://orcid.org/0000-0001-6145-9040"},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz Medical Campus","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas W. Flaig","raw_affiliation_strings":["University of Colorado School of Medicine, Anschutz Medical Campus, Aurora"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado School of Medicine, Anschutz Medical Campus, Aurora","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034069506","display_name":"Heidi S. Wirtz","orcid":"https://orcid.org/0000-0003-4755-7159"},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heidi S. Wirtz","raw_affiliation_strings":["Pfizer, Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Bothell, WA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015645624","display_name":"Michael Mihm","orcid":null},"institutions":[{"id":"https://openalex.org/I4210165171","display_name":"Astellas Pharma (United States)","ror":"https://ror.org/05pw69n24","country_code":"US","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210165171"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Mihm","raw_affiliation_strings":["Astellas Pharma, Northbrook, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astellas Pharma, Northbrook, IL","institution_ids":["https://openalex.org/I4210165171"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5137115809","display_name":"Qinlei Huang","orcid":null},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qinlei Huang","raw_affiliation_strings":["Merck, Rahway, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005778227","display_name":"Aljosja Rogiers","orcid":"https://orcid.org/0000-0002-3807-9696"},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aljosja Rogiers","raw_affiliation_strings":["Merck, Rahway, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082742595","display_name":"Blanca Homet Moreno","orcid":"https://orcid.org/0000-0001-6712-8330"},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Blanca Homet Moreno","raw_affiliation_strings":["Merck, Rahway, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066554562","display_name":"Alfonso G\u00f3mez de Lia\u00f1o","orcid":"https://orcid.org/0000-0002-1844-8474"},"institutions":[{"id":"https://openalex.org/I2799299272","display_name":"Hospital Universitario Insular de Gran Canaria","ror":"https://ror.org/04cbm7s05","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2799299272","https://openalex.org/I4210120310"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alfonso G\u00f3mez de Lia\u00f1o","raw_affiliation_strings":["Complejo Hospitalario Universitario Insular\u2013Materno Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas, Spain"],"raw_orcid":"https://orcid.org/0000-0002-1844-8474","affiliations":[{"raw_affiliation_string":"Complejo Hospitalario Universitario Insular\u2013Materno Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas, Spain","institution_ids":["https://openalex.org/I2799299272"]}]}],"institutions":[],"countries_distinct_count":13,"institutions_distinct_count":35,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":61.6439,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.99917133,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"395","issue":"4","first_page":"338","last_page":"348"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9739000201225281,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9739000201225281,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12695","display_name":"Urinary and Genital Oncology Studies","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"Pembrolizumab","score":0.8743000030517578},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"Bladder cancer","score":0.6402999758720398},{"id":"https://openalex.org/keywords/bladder-tumor","display_name":"Bladder tumor","score":0.38580000400543213},{"id":"https://openalex.org/keywords/cancer","display_name":"Cancer","score":0.3181999921798706},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"Immunotherapy","score":0.31610000133514404},{"id":"https://openalex.org/keywords/antibody","display_name":"Antibody","score":0.2734000086784363}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8743000030517578},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8302000164985657},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.6402999758720398},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5900999903678894},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5753999948501587},{"id":"https://openalex.org/C2992225637","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder tumor","level":4,"score":0.38580000400543213},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3181999921798706},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.31610000133514404},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2734000086784363},{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.2696000039577484},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2687999904155731},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.26339998841285706},{"id":"https://openalex.org/C2779762690","wikidata":"https://www.wikidata.org/wiki/Q9382","display_name":"Urinary bladder","level":2,"score":0.2628999948501587},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.2603999972343445},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2596000134944916}],"mesh":[{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000095384","descriptor_name":"Pathologic Complete Response","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001743","descriptor_name":"Urinary Bladder","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001743","descriptor_name":"Urinary Bladder","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008197","descriptor_name":"Lymph Node Excision","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009361","descriptor_name":"Neoplasm Invasiveness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015653","descriptor_name":"Cystectomy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1056/nejmoa2601486","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejmoa2601486","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:42485627","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42485627","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320332932","display_name":"Merck Sharp and Dohme","ror":null}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1974722941","https://openalex.org/W1975918912","https://openalex.org/W2103561213","https://openalex.org/W2113156769","https://openalex.org/W2897581535","https://openalex.org/W3127912627","https://openalex.org/W3163995648","https://openalex.org/W3196747859","https://openalex.org/W4293698156","https://openalex.org/W4382198144","https://openalex.org/W4387807073","https://openalex.org/W4387859553","https://openalex.org/W4392498919","https://openalex.org/W4392769651","https://openalex.org/W4400272904","https://openalex.org/W4402548582","https://openalex.org/W4402552345","https://openalex.org/W4415351494","https://openalex.org/W7130433278"],"related_works":[],"abstract_inverted_index":{"BACKGROUND:":[0],"Neoadjuvant":[1],"cisplatin-based":[2,27,53,320],"chemotherapy":[3,28,54],"is":[4],"a":[5,39,335],"standard":[6],"therapy":[7,111],"for":[8,52,241,265,319],"muscle-invasive":[9,48,315],"bladder":[10,49,316],"cancer.":[11],"The":[12,148,186,290],"efficacy":[13],"and":[14,18,55,85,87,98,104,141,146,162,181,214,235,260,284,307,330,334,360,362],"safety":[15],"of":[16,79,101,107,125,172,204,206,216,286,292,299,339,351],"neoadjuvant":[17,26,68,115,344],"adjuvant":[19,110],"(perioperative)":[20],"enfortumab":[21,69,73,102,179,211,233,305,323],"vedotin-pembrolizumab":[22,70,180,212,234,306,324],"as":[23,109],"compared":[24],"with":[25,31,47,58,232,237,304,309,314,347],"in":[29,209,218,282],"persons":[30],"this":[32],"cancer":[33,50,317],"are":[34],"unclear.":[35],"METHODS:":[36],"We":[37],"conducted":[38],"phase":[40],"3,":[41],"open-label,":[42],"randomized":[43],"trial":[44],"involving":[45],"adults":[46],"eligible":[51,318],"radical":[56],"cystectomy":[57],"pelvic":[59],"lymph-node":[60],"dissection":[61],"(cystectomy).":[62],"Participants":[63],"were":[64,159,175],"assigned":[65,176],"to":[66,113,177,183,191,200,252,271,326],"receive":[67,114,178,184],"(4":[71,117],"cycles;":[72,118],"vedotin":[74,103],"[1.25":[75],"mg":[76,90,121,134],"per":[77,122,135],"kilogram":[78],"body":[80],"weight":[81],"on":[82,91,128,138],"days":[83,139],"1":[84,140],"8]":[86,142],"pembrolizumab":[88,108],"[200":[89],"day":[92,129],"1]":[93,130],"every":[94,143],"3":[95,144,294,353],"weeks),":[96],"cystectomy,":[97],"5":[99],"cycles":[100,106],"13":[105],"or":[112,244,295,354],"cisplatin-gemcitabine":[116,220,238],"cisplatin":[119],"[70":[120],"square":[123,136],"meter":[124,137],"body-surface":[126],"area":[127],"plus":[131],"gemcitabine":[132],"[1000":[133],"weeks)":[145],"cystectomy.":[147,223],"primary":[149],"end":[150,157],"point":[151],"was":[152,167,195,230,258,302],"event-free":[153,228,329],"survival;":[154],"key":[155],"secondary":[156],"points":[158],"overall":[160,256,331],"survival":[161,229,257,332],"pathological":[163,278,340],"complete":[164,279,341],"response.":[165],"Safety":[166],"assessed.":[168],"RESULTS:":[169],"A":[170,202,277],"total":[171,203],"405":[173],"participants":[174,208,288,313],"403":[182],"cisplatin-gemcitabine.":[185,310],"median":[187],"time":[188],"from":[189],"randomization":[190],"the":[192,207,210,219,287],"data-cutoff":[193],"date":[194],"33.6":[196],"months":[197],"(range,":[198],"22.5":[199],"53.6).":[201],"86.7%":[205],"group":[213,221],"89.6%":[215],"those":[217],"underwent":[222],"At":[224],"2":[225],"years,":[226],"estimated":[227,255],"79.4%":[231],"66.2%":[236],"(hazard":[239,263],"ratio":[240,264],"an":[242],"event":[243],"death,":[245,266],"0.53;":[246],"95%":[247,268],"confidence":[248],"interval":[249],"[CI],":[250],"0.41":[251],"0.70;":[253],"P<0.001);":[254],"86.9%":[259],"81.3%,":[261],"respectively":[262],"0.65;":[267],"CI,":[269],"0.48":[270],"0.89;":[272],"two-sided":[273],"P":[274],"=":[275],"0.006).":[276],"response":[280,342],"occurred":[281],"55.8%":[283],"32.5%":[285],"(P<0.001).":[289],"incidence":[291,338],"grade":[293,352],"higher":[296,337],"adverse":[297,349],"events":[298,350],"any":[300],"cause":[301],"75.7%":[303],"67.2%":[308],"CONCLUSIONS:":[311],"Among":[312],"chemotherapy,":[321],"perioperative":[322],"led":[325],"significantly":[327,336],"better":[328],"outcomes":[333],"than":[343],"cisplatin-gemcitabine,":[345],"but":[346],"more":[348],"higher.":[355],"(Funded":[356],"by":[357],"Merck":[358],"Sharp":[359],"Dohme":[361],"others;":[363],"KEYNOTE-B15/EV-304":[364],"ClinicalTrials.gov":[365],"number,":[366],"NCT04700124.).":[367]},"counts_by_year":[{"year":2026,"cited_by_count":6}],"updated_date":"2026-07-30T17:31:21.811387","created_date":"2026-07-23T00:00:00"}